The United States and Rwanda have signed a five-year, $228 million health partnership designed to strengthen Rwanda’s healthcare system and improve long-term self-reliance. Announced by the U.S. State Department, the agreement is the second deal finalized under the Trump administration’s “America First Global Health Strategy,” following a similar pact with Kenya earlier in the week. The initiative aims to help partner nations build sustainable, locally driven health programs while supporting global health security.
Under the new agreement, the U.S. will contribute up to $158 million to support Rwanda’s efforts to combat HIV/AIDS, malaria, and other infectious diseases. Funding will also enhance disease surveillance, emergency response capacity, and overall health-system resilience. In parallel, the government of Rwanda has committed to increasing its own domestic health spending by $70 million, signaling a long-term shift toward national ownership as American support gradually tapers.
U.S. officials highlighted that the partnership reflects a shared vision to save lives and improve Rwanda’s health infrastructure while contributing to broader regional stability. The announcement came shortly after Rwandan President Paul Kagame and Democratic Republic of the Congo President Felix Tshisekedi reaffirmed their commitment to a U.S.-brokered effort aimed at easing tensions in eastern Congo.
The deal will also expand Rwanda’s use of innovative healthcare technologies, including drone delivery of medical supplies through Zipline, a startup known for rapidly transporting blood, vaccines, and other critical products to remote areas. According to Rwanda’s foreign minister Oliver Nduhungirehe, the agreement demonstrates the nation’s determination to build a self-sufficient, adaptive, and technology-driven health system capable of meeting current and future challenges.
By aligning financial investment with emerging technologies and public-health goals, the partnership aims to strengthen care delivery, reduce disease burden, and reinforce Rwanda’s progress toward long-term health independence.


FDA Warns Novo Nordisk Over Misleading Ozempic Ad Claims
Ukrainian Drone Strikes Hit Novorossiysk, Injuring Eight and Cutting Power Across Russia
Moderna Stock Drops After FDA Declines Review of mRNA Flu Vaccine
How will the Iran war change the Middle East? We asked 5 experts
Novo Nordisk Shares Tumble After CagriSema Misses Key Trial Endpoint
Trump Administration Terminates Title IX Agreements Protecting Transgender Students
CDC Acting Director Urges Measles Vaccination as U.S. Cases Surge in 2026
Novocure Stock Surges 30% After FDA Approves Optune Pax for Pancreatic Cancer Treatment
Viking Therapeutics Sees Growing Strategic Interest in $150 Billion Weight-Loss Drug Market
Iran Rejects Trump's Hormuz Ultimatum, Threatens Wider Trade Disruption
U.S. Vaccine Policy Shifts Under RFK Jr. Create Uncertainty for Pharma and Investors
Iran-US Ceasefire Talks: Pakistan Brokers "Islamabad Accord" to Reopen Strait of Hormuz
Trump Issues Deadline for Iran to Reopen Strait of Hormuz Amid Escalating Conflict
Moderna to Pay Up to $2.25B to Settle LNP Patent Dispute Over COVID-19 Vaccine Technology
Is dark chocolate healthier than milk chocolate? 2 dietitians explain 



